Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease.

Kankaanpää J, Turunen SP, Moilanen V, Hörkkö S, Remes AM.

Neurobiol Dis. 2009 Mar;33(3):467-72. doi: 10.1016/j.nbd.2008.12.001. Epub 2008 Dec 16.

PMID:
19130885
2.

Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.

Tsimikas S, Bergmark C, Beyer RW, Patel R, Pattison J, Miller E, Juliano J, Witztum JL.

J Am Coll Cardiol. 2003 Feb 5;41(3):360-70.

3.

Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.

Cvetkovic JT, Wållberg-Jonsson S, Ahmed E, Rantapää-Dahlqvist S, Lefvert AK.

Rheumatology (Oxford). 2002 Sep;41(9):988-95.

PMID:
12209031
4.

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.

Tsimikas S, Brilakis ES, Lennon RJ, Miller ER, Witztum JL, McConnell JP, Kornman KS, Berger PB.

J Lipid Res. 2007 Feb;48(2):425-33. Epub 2006 Nov 8.

5.

High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.

Santos AO, Fonseca FA, Fischer SM, Monteiro CM, Brandão SA, Póvoa RM, Bombig MT, Carvalho AC, Monteiro AM, Ramos E, Gidlund M, Figueiredo Neto AM, Izar MC.

Clin Chim Acta. 2009 Aug;406(1-2):113-8. doi: 10.1016/j.cca.2009.06.005. Epub 2009 Jun 10.

PMID:
19523463
6.

Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.

McIntyre JA, Chapman J, Shavit E, Hamilton RL, Dekosky ST.

Autoimmunity. 2007 Jul;40(5):390-6.

PMID:
17612901
7.

Oxidized low-density lipoprotein and autoimmune antibodies in patients with antiphospholipid syndrome with a history of thrombosis.

Zhao D, Ogawa H, Wang X, Cameron GS, Baty DE, Dlott JS, Triplett DA.

Am J Clin Pathol. 2001 Nov;116(5):760-7.

PMID:
11710695
8.

Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.

Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J, Witztum JL, Xu Q.

J Am Coll Cardiol. 2006 Jun 20;47(12):2436-43. Epub 2006 May 30.

9.

Lysophosphatidylcholine is involved in the antigenicity of oxidized LDL.

Wu R, Huang YH, Elinder LS, Frostegård J.

Arterioscler Thromb Vasc Biol. 1998 Apr;18(4):626-30.

PMID:
9555869
10.

IgG-autoantibodies against oxidized low-density lipoprotein in ischemic stroke onset.

Cojocaru IM, Cojocaru M, Burcin C.

Rom J Intern Med. 2006;44(2):165-70.

PMID:
17236297
11.

Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.

Smook ML, van Leeuwen M, Heeringa P, Damoiseaux JG, Theunissen R, Daemen MJ, Lutgens E, Tervaert JW.

Clin Exp Immunol. 2008 Nov;154(2):264-9. doi: 10.1111/j.1365-2249.2008.03746.x. Epub 2008 Sep 5.

12.

Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.

Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.

Minerva Cardioangiol. 2007 Dec;55(6):821-37. Review.

PMID:
18091649
13.

Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.

Tsimikas S, Lau HK, Han KR, Shortal B, Miller ER, Segev A, Curtiss LK, Witztum JL, Strauss BH.

Circulation. 2004 Jun 29;109(25):3164-70. Epub 2004 Jun 7.

PMID:
15184281
14.

Humoral responses to oxidized low-density lipoprotein and related bacterial antigens after pneumococcal vaccine.

Nguyen JT, Myers N, Palaia J, Georgopoulos A, Rubins JB, Janoff EN.

Transl Res. 2007 Sep;150(3):172-9. Epub 2007 May 25.

PMID:
17761370
15.

Local production of mumps IgG and IgM antibodies in the cerebrospinal fluid of meningitis patients.

Ukkonen P, Granström ML, Räsänen J, Salonen EM, Penttinen K.

J Med Virol. 1981;8(4):257-65.

PMID:
7334360
16.

Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus.

Lopez LR, Hurley BL, Simpson DF, Matsuura E.

Ann N Y Acad Sci. 2005 Jun;1051:97-103.

PMID:
16126948
17.

Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.

Kobayashi K, Tada K, Itabe H, Ueno T, Liu PH, Tsutsumi A, Kuwana M, Yasuda T, Shoenfeld Y, de Groot PG, Matsuura E.

Lupus. 2007;16(12):929-38. Erratum in: Lupus. 2008;17(1):75.

PMID:
18042586
18.

Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytes.

Craig WY, Poulin SE, Neveux LM, Palomaki GE, Dostal-Johnson DA, Ledue TB, Ritchie RF.

J Autoimmun. 1995 Oct;8(5):713-26.

PMID:
8579726
19.

Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.

Vuilleumier N, Charbonney E, Fontao L, Alvarez M, Turck N, Sanchez JC, Burkhard PR, Mensi N, Righini M, Reber G, James R, Mach F, Chevrolet JC, Dayer JM, Frostegard J, Roux-Lombard P.

Clin Sci (Lond). 2008 Jul;115(1):25-33.

PMID:
18088236
20.

Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients.

Henkel AW, Dittrich PS, Groemer TW, Lemke EA, Klingauf J, Klafki HW, Lewczuk P, Esselmann H, Schwille P, Kornhuber J, Wiltfang J.

Mol Psychiatry. 2007 Jun;12(6):601-10. Epub 2007 Feb 6.

PMID:
17279093

Supplemental Content

Support Center